BRPI1007399A2 - Formulações de emulsão narcótica para o tratamento de dor de câncer - Google Patents
Formulações de emulsão narcótica para o tratamento de dor de câncerInfo
- Publication number
- BRPI1007399A2 BRPI1007399A2 BRPI1007399-0A BRPI1007399A BRPI1007399A2 BR PI1007399 A2 BRPI1007399 A2 BR PI1007399A2 BR PI1007399 A BRPI1007399 A BR PI1007399A BR PI1007399 A2 BRPI1007399 A2 BR PI1007399A2
- Authority
- BR
- Brazil
- Prior art keywords
- cancer pain
- emulsion formulations
- pain treatment
- narcotic emulsion
- narcotic
- Prior art date
Links
- 206010058019 Cancer Pain Diseases 0.000 title 1
- 239000000839 emulsion Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000003533 narcotic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15585309P | 2009-02-26 | 2009-02-26 | |
| PCT/US2010/020645 WO2010098897A1 (en) | 2009-02-26 | 2010-01-11 | Narcotic emulsion formulations for treatment of cancer pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1007399A2 true BRPI1007399A2 (pt) | 2015-08-25 |
Family
ID=42631520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007399-0A BRPI1007399A2 (pt) | 2009-02-26 | 2010-01-11 | Formulações de emulsão narcótica para o tratamento de dor de câncer |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8871791B2 (pt) |
| EP (1) | EP2400838B1 (pt) |
| JP (2) | JP5619780B2 (pt) |
| KR (2) | KR20110099747A (pt) |
| CN (1) | CN102333443A (pt) |
| AU (1) | AU2010218424B2 (pt) |
| BR (1) | BRPI1007399A2 (pt) |
| CA (1) | CA2752639A1 (pt) |
| EA (1) | EA201190135A1 (pt) |
| IL (1) | IL213940A0 (pt) |
| MX (1) | MX2011007885A (pt) |
| NZ (1) | NZ594486A (pt) |
| SG (1) | SG174157A1 (pt) |
| TW (1) | TWI446932B (pt) |
| WO (1) | WO2010098897A1 (pt) |
| ZA (1) | ZA201104963B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
| EA201190135A1 (ru) | 2009-02-26 | 2012-07-30 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Композиции на основе эмульгированных наркотических веществ для лечения боли при раке |
| US9155734B2 (en) | 2012-03-07 | 2015-10-13 | Mallinckrodt Llc | Stability of hydromorphone hydrochloride solutions |
| WO2013134362A1 (en) * | 2012-03-07 | 2013-09-12 | Mallinckrodt Llc | Improved stability of hydromorphone hydrochloride solutions |
| US11213486B2 (en) | 2017-01-12 | 2022-01-04 | Techno Guard Co. Ltd. | Drug-containing fat emulsion and nethod for producing same |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | ４−ビフエニリル酢酸系化合物含有脂肪乳剤 |
| JPS6211915A (ja) | 1985-07-10 | 1987-01-20 | Hitachi Ltd | 電力系統の無効電力補償装置 |
| US4816247A (en) * | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
| ES2138130T3 (es) * | 1995-10-28 | 2000-01-01 | Braun Melsungen Ag | Composicion farmaceutica que contiene un anestesico local y/o un analgesico de accion central. |
| GB9721746D0 (en) * | 1997-10-15 | 1997-12-10 | Panos Therapeutics Limited | Compositions |
| US6455525B1 (en) | 1999-11-04 | 2002-09-24 | Cephalon, Inc. | Heterocyclic substituted pyrazolones |
| US7211596B2 (en) | 2001-05-11 | 2007-05-01 | Mitsubishi Pharma Corporation | Stable high-concentration injection containing pyrazolone derivative |
| JP2004043479A (ja) * | 2002-07-11 | 2004-02-12 | Taiho Yakuhin Kogyo Kk | 経鼻吸収用組成物 |
| US7252822B2 (en) | 2002-10-08 | 2007-08-07 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist |
| JP2007538091A (ja) * | 2004-05-17 | 2007-12-27 | ファーマコフォア・インコーポレイテッド | 痛みを処置または予防するための組成物および方法 |
| DE102004025357B4 (de) | 2004-05-19 | 2007-03-29 | Beiersdorf Ag | Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung |
| US7871632B2 (en) * | 2004-07-12 | 2011-01-18 | Adventrx Pharmaceuticals, Inc. | Compositions for delivering highly water soluble drugs |
| US20070087977A1 (en) * | 2004-11-16 | 2007-04-19 | Wendye Robbins | Methods and compositions for treating pain |
| US20060189682A1 (en) | 2005-02-02 | 2006-08-24 | Payne Joseph E | Water soluble prodrugs of COX-2 inhibitors |
| CN101137395B (zh) * | 2005-03-14 | 2012-10-31 | 株式会社大塚制药工场 | 含有水难溶性药物的医药组合物 |
| CA2608111A1 (en) * | 2005-04-22 | 2006-11-02 | Novacardia, Inc. | Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
| DK1976521T3 (en) | 2006-01-25 | 2015-04-27 | Insys Therapeutics Inc | Sublingual fentanyl spray |
| WO2007103185A2 (en) | 2006-03-01 | 2007-09-13 | University Of Tennessee Research Foundation | Sustained release dosage forms of analagesic medications |
| US20080287494A1 (en) * | 2007-04-24 | 2008-11-20 | Cephalon, Inc. | Transmucosal treatment methods in patients with mucositis |
| CN101066245A (zh) | 2007-05-25 | 2007-11-07 | 朱芳海 | 一种口服乳剂及其制备方法 |
| US7779136B2 (en) | 2007-11-01 | 2010-08-17 | Telefonaktiebolaget L M Ericsson (Publ) | Secure neighbor discovery between hosts connected through a proxy |
| CN101199525A (zh) | 2007-12-15 | 2008-06-18 | 王鸿英 | 一种丙泊酚静脉混合注射剂及其制备方法 |
| US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
| EA201190135A1 (ru) * | 2009-02-26 | 2012-07-30 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Композиции на основе эмульгированных наркотических веществ для лечения боли при раке |
-
2010
- 2010-01-11 EA EA201190135A patent/EA201190135A1/ru unknown
- 2010-01-11 MX MX2011007885A patent/MX2011007885A/es unknown
- 2010-01-11 EP EP10746581.7A patent/EP2400838B1/en not_active Not-in-force
- 2010-01-11 US US12/685,401 patent/US8871791B2/en not_active Expired - Fee Related
- 2010-01-11 WO PCT/US2010/020645 patent/WO2010098897A1/en not_active Ceased
- 2010-01-11 SG SG2011061488A patent/SG174157A1/en unknown
- 2010-01-11 NZ NZ594486A patent/NZ594486A/xx not_active IP Right Cessation
- 2010-01-11 KR KR1020117016845A patent/KR20110099747A/ko not_active Ceased
- 2010-01-11 CA CA2752639A patent/CA2752639A1/en not_active Abandoned
- 2010-01-11 KR KR1020147006765A patent/KR101564058B1/ko not_active Expired - Fee Related
- 2010-01-11 JP JP2011552037A patent/JP5619780B2/ja not_active Expired - Fee Related
- 2010-01-11 BR BRPI1007399-0A patent/BRPI1007399A2/pt not_active IP Right Cessation
- 2010-01-11 AU AU2010218424A patent/AU2010218424B2/en not_active Ceased
- 2010-01-11 CN CN2010800091439A patent/CN102333443A/zh active Pending
- 2010-02-25 TW TW099105534A patent/TWI446932B/zh not_active IP Right Cessation
-
2011
- 2011-07-05 IL IL213940A patent/IL213940A0/en unknown
- 2011-07-06 ZA ZA2011/04963A patent/ZA201104963B/en unknown
-
2014
- 2014-05-22 JP JP2014106384A patent/JP5978248B2/ja not_active Expired - Fee Related
- 2014-09-22 US US14/492,509 patent/US9427435B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL213940A0 (en) | 2011-07-31 |
| JP5978248B2 (ja) | 2016-08-24 |
| EA201190135A1 (ru) | 2012-07-30 |
| CA2752639A1 (en) | 2010-09-02 |
| MX2011007885A (es) | 2011-12-08 |
| SG174157A1 (en) | 2011-10-28 |
| JP2014205680A (ja) | 2014-10-30 |
| JP2012519167A (ja) | 2012-08-23 |
| EP2400838A1 (en) | 2012-01-04 |
| US20150141461A1 (en) | 2015-05-21 |
| TW201038297A (en) | 2010-11-01 |
| TWI446932B (zh) | 2014-08-01 |
| CN102333443A (zh) | 2012-01-25 |
| AU2010218424B2 (en) | 2014-02-13 |
| NZ594486A (en) | 2013-07-26 |
| KR20110099747A (ko) | 2011-09-08 |
| US9427435B2 (en) | 2016-08-30 |
| US20100216842A1 (en) | 2010-08-26 |
| US8871791B2 (en) | 2014-10-28 |
| WO2010098897A1 (en) | 2010-09-02 |
| EP2400838A4 (en) | 2012-08-01 |
| KR20140041944A (ko) | 2014-04-04 |
| KR101564058B1 (ko) | 2015-10-29 |
| AU2010218424A1 (en) | 2011-09-01 |
| JP5619780B2 (ja) | 2014-11-05 |
| EP2400838B1 (en) | 2016-05-11 |
| ZA201104963B (en) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013011874A2 (pt) | compostos e métodos para tratar dor | |
| BR212013028314U2 (pt) | método para tratar câncer e dor de câncer de osso | |
| BR112012031836A2 (pt) | combinação farmacêutica para o tratamento da dor | |
| BRPI1008566A2 (pt) | métodos e composições para o diagnóstico e tratamento de câncer | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0821660A2 (pt) | Combinações de agentes terapêuticos para tratamento de câncer | |
| BRPI0810082A2 (pt) | 3-imidazolil-indóis para o tratamento de doenças proliferativas | |
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| BR112012018947A2 (pt) | composição farmacêutica para tratamento e\ou prevenção do cancêr | |
| PT2340042E (pt) | Métodos e composições para o tratamento de cancro | |
| PT2709604T (pt) | Canabidivarina para utilização no tratamento de dor neuropática | |
| BRPI1007972A2 (pt) | composições de combinação e métodos para o tratamento de câncer | |
| BR112012001819A2 (pt) | métodos para tratamento de dor | |
| DK2121139T3 (da) | Formulations for cancer treatment | |
| BRPI0907135A2 (pt) | Processos de tratamento de dor crônica | |
| BR112013014583A2 (pt) | composição farmacêutica, e, métodos para o tratamento de inflamação, para o tratamento da dor, e para preparar 3-metanossulfonilpropionitrila | |
| BRPI1014528A2 (pt) | compostos para tratamento de inflamação e dor | |
| BR112012000502A2 (pt) | terapia de combinação para o tratamento de diabetes | |
| BRPI0909164A2 (pt) | método e composições para o tratamento de câncer | |
| PT2632452T (pt) | Compostos e composições para o tratamento do cancro | |
| BRPI0922884A2 (pt) | compostos para tratamento de câncer | |
| EP3381471C0 (en) | PAIN TREATMENT | |
| BRPI0922367A2 (pt) | enzastaurin para o tratamento de câncer | |
| BRPI0923688A2 (pt) | compostos e métodos para o tratamento de dor e outras doenças |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |